- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00345085
Comparison of Higher Order Aberrations and Contrast Sensitivity Between Acrysof SN60AT, SN60WF and Restore Intraocular Lenses
July 24, 2014 updated by: University of Texas Southwestern Medical Center
This project involves evaluation of post operative contrast sensitivity and wavefront aberration results among patients implanted with standard monofocal lenses (Acrysof SN60AT/SN60WF) and the new presbyopic correcting multifocal lens (Acrysof ReSTOR).
Higher Order aberrations are visual phenomena such as glare and haloes.
They are more prevalent after cataract surgery and can affect night driving.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The Project involves evaluation of contrast sensitivity and higher order aberrations in patients implanted with SN60AT, SN60WF and ReSTOR intraocular lenses.
Patients in the department of Ophthalmology will be asked to participate in the study on a routine postoperative visit at least 3 months after cataract surgery.
Patients will be asked to sign a consent form prior to participation.
Wavefront analysis involves the patient resting their chin in a device similar to a slit lamp; they focus on a distant light and the machine performs the measurements in mesopic and scotopic conditions (light and dark).
Contrast sensitivity is a measure of how faded or washed out an image can be before it becomes indistinguishable from a uniform field; it involves the patient identifying patterns on a chart.
Wavefront analysis and contrast sensitivity are noninvasive tests that do not employ sedation or anesthesia and does not expose the patient to x-rays or microwaves.
The proposed research will not alter usual standard postoperative care and can be done on a routine office visit.
Study Type
Observational
Enrollment (Actual)
40
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Dallas, Texas, United States, 75390-8866
- UTSW Medical Center at Dallas
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria: All subject implanted with either SN60AT, SN60WF or ReSTOR intraocular lenses after cataract removal. Subjects include those 18 yrs and over, male and female, all races. Patients will sign an informed consent
Exclusion Criteria: Patients younger than 18 yrs. Patients with other concurrent visually significant ophthalmic disease.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
post operative wavefront aberration
|
Secondary Outcome Measures
Outcome Measure |
---|
post operative contrast sensitivity
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: James P McCulley, M.D., UTSW Medical Center at Dallas
- Principal Investigator: Shady Awwad, M.D., UTSW Medical Center at Dallas
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2005
Study Completion (Actual)
April 1, 2007
Study Registration Dates
First Submitted
June 23, 2006
First Submitted That Met QC Criteria
June 23, 2006
First Posted (Estimate)
June 27, 2006
Study Record Updates
Last Update Posted (Estimate)
July 25, 2014
Last Update Submitted That Met QC Criteria
July 24, 2014
Last Verified
June 1, 2008
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 052006-029
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Refractive Errors
-
Suzan A RattanCompletedRefractive Errors | Refractive SurgeryIraq
-
London School of Hygiene and Tropical MedicineBritish Council for Prevention of Blindness; Tanzanian Society for the BlindCompletedUnder- and Uncorrected Significant Refractive ErrorsTanzania
-
Johnson & Johnson Vision Care, Inc.TerminatedRefractive Error CorrectionUnited States
-
Alcon ResearchCompletedRefractive ErrorsUnited States
-
Alcon ResearchCompletedRefractive ErrorsUnited States
-
Alcon ResearchCompletedRefractive ErrorsUnited States
-
Ohio State UniversityNational Eye Institute (NEI); University of HoustonCompleted
-
Coopervision, Inc.Completed
Clinical Trials on Wavefront and Contrast Sensitivity
-
Siriraj HospitalCompletedSenile Cataract | Primary Angle Closure Glaucoma | Primary Angle Glaucoma Closure SuspectThailand
-
Aston UniversityThe Dunhill Medical TrustCompletedAge Related Macular DegenerationUnited Kingdom
-
University Hospital, Strasbourg, FranceCompletedCannabis Dependence
-
Moorfields Eye Hospital NHS Foundation TrustCompletedAge Related Macular DegenerationUnited Kingdom
-
Nova Southeastern UniversityAdaptive Sensory TechnologyCompleted
-
Dar Al Shifa HospitalCompleted
-
University of OxfordCompleted
-
Democritus University of ThraceCompletedRefractive Errors | Cataract | PresbyopiaGreece
-
Walter Reed Army Medical CenterCompleted